Sign in
Taking peopleNo phase

Wearable exoskeleton versus usual therapy for walking recovery after spinal cord injury

Compares a wearable walking robot with usual therapy in people with recent spinal cord injury.

Key facts

Who runs it
ABLE Human Motion S.L.
Where
Spain2 sites in 1 countryChoose a country to see its sites
Trial code
Registry title
A Trial on the Clinical and Socioeconomic Impact of Wearable Exoskeletons for Spinal Cord Injury Rehabilitation in the Spanish Healthcare System
Status
Recruiting
People taking part
80 people, planned
Started
15 Jan 2026
Expected to end
30 Sept 2027
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • ABLE Exoskeleton
  • Conventional therapy
Record updated
27 January 2026

Who can take part

The trial is looking for adults with a recent spinal cord injury, less than 6 months old. It compares walking training with a wearable robotic exoskeleton (ABLE Exoskeleton) to conventional therapy.

Age
18 to 70 years
Sex
All sexes
Disease stage
Spinal cord injury in the acute or subacute phase (< 6 months), traumatic or non-traumatic. Injury level C5 to L5 for AIS C or D, or C7 to L5 for AIS A or B. Arms strong enough to use a walker (triceps score ≥ 4 on the MRC scale). Leg stiffness (spasticity) score ≤ 3 on the Modified Ashworth Scale. Legs must move freely: at least 10 degrees of knee extension and a neutral ankle position. Must tolerate standing (has stood up in the last year). Height 150 cm (4 ft 11 in) to 190 cm (6 ft 3 in), weight less than 100 kg (220 lb).
Earlier treatment
People who have already had robot-assisted walking training (RAGT) cannot join.
Main reasons for not taking part
  • Walking score WISCI ≥ 15
  • Thinking or nerve problems that prevent following instructions, or another nerve disease affecting walking
  • Pressure sores (grade I or higher) where the exoskeleton touches the body
  • Unhealed fractures, an unstable spine, or stiff or fused joints
  • Uncontrolled epilepsy or uncontrolled autonomic dysautonomia, exercise intolerance, or a drop of more than 3 points in motor score in the last 4 weeks
Show the full registry criteria (20)Hide the full registry criteria

Who can take part

  • diagnosis of spinal cord injury (SCI) in the acute or subacute phase (< 6 months of evolution)
  • traumatic or non-traumatic aetiology
  • neurological level of the SCI between C5 and L5 for patients with American Spinal Injury Association Impairment Scale (AIS) C or D, and SCI between C7 and L5 for patients with AIS A or B
  • sufficient strength in the upper extremities to handle a walker (triceps muscle score ≥ 4 according to the Medical Research Council (MRC) scale)
  • range of motion (ROM) without limitations in the lower extremities (achieve at least a knee extension of 10 degrees and neutral ankle position)
  • muscle spasticity in the lower extremities with a score ≤ 3 on the Modified Ashworth Scale (MAS)
  • tolerate bipedalism (having stood up in the last year)
  • aged between 18 and 70 years, with height between 150 cm and 190 cm, and weight less than 100 kg

Who cannot take part

  • previous experience with Robotic-Assisted Gait Training (RAGT)
  • another neurologic disorder permanently affecting gait and gait therapy (other than SCI)
  • grade I or higher in the European Pressure Ulcer Advisory Panel (EPUAP) in the areas of contact with the exoskeleton
  • uncontrolled epilepsy
  • WISCI ≥ 15
  • cognitive or neurological limitations that prevent following instructions
  • unresolved fractures at the time of the study
  • uncontrolled autonomic dysautonomia
  • intolerance to exercise
  • ROM restriction such as flexing or arthrodesis will be excluded
  • spinal instability (or spinal orthotics unless cleared by a medical doctor)
  • deterioration >3 points of the total in the motor score of the International Standards for the Neurological Classification of Spinal Cord Injury (ISNCSCI) in the last 4 weeks. Loss of sensation and/or motor activity above the level of injury detected that has not been evaluated by a doctor

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Spinal cord injury

This trial is currently available in Spain.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This clinical trial aims to collect evidence on the clinical benefits and the socioeconomic impact of integrating a novel wearable powered lower-limb exoskeleton for gait rehabilitation in acute/subacute spinal cord injured individuals and to evaluate the efficiency of this technology to the current standard of care in the Spanish Healthcare System (SNS).. The main questions it aims to answer are:

Read full original descriptionShow less

* Is robotic therapy for gait rehabilitation more effective and efficient than conventional therapy? * Does robotic therapy for gait rehabilitation reduce the burden on healthcare professionals and caregivers? * Does robotic therapy for gait rehabilitation reduce direct healthcare costs? * Does robotic therapy for gait rehabilitation reduce intervention-related costs?

Researchers will compare a novel wearable powered lower-limb exoskeleton for gait rehabilitation to conventional therapy to see if the robotic exoskeleton is more effective and efficient in improving clinical benefits and to assess if it reduces the burden of healthcare professionals and caregivers, as well as healthcare and intervention-related costs.

Participants will:

* Be randomized on a 1:1 basis to receive rehabilitation treatment with either the robotic exoskeleton or conventional therapy for gait recovery, 3 times a week on non-consecutive days for 8 weeks (24-session program). * Undergo a pre- and post-intervention assessment of clinical, functional, physiological, psychological, and socioeconomic variables. * Have a follow-up visit 2 months after the end of the treatment.

The 2 groups in the trial

  • Robotic exoskeletonTreatment being tested

    The intervention group will receive rehabilitation treatment with the ABLE Exoskeleton

    Treatment: ABLE Exoskeleton

  • Conventional therapyExisting treatment, for comparison

    The control group will receive conventional therapy for gait rehabilitation

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Robotic-SNS: A Multicenter, Randomized Trial on the Clinical and Socioeconomic Impact of Wearable Exoskeletons for Spinal Cord Injury Rehabilitation in the Spanish Healthcare System
Plain-language title
Wearable exoskeleton versus usual therapy for walking recovery after spinal cord injuryGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Criteria questions
Built from NCT07036107, who can take part
Record updated
27 January 2026